VSGAX | YOVIX | VSGAX / YOVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 9 years | - |
Gain YTD | -0.325 | 2.962 | -11% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 39.6B | 30.4M | 130,263% |
Annual Yield % from dividends | 0.66 | 0.22 | 303% |
Returns for 1 year | 12.95 | 6.17 | 210% |
Returns for 3 years | 19.38 | -2.57 | -754% |
Returns for 5 years | 35.62 | 29.45 | 121% |
Returns for 10 years | 116.34 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TRNZX | 20.86 | -0.07 | -0.33% |
T. Rowe Price International Stock Z | |||
FBDIX | 123.32 | -0.72 | -0.58% |
Franklin Biotechnology Discovery A | |||
EMAAX | 15.02 | -0.16 | -1.05% |
Gabelli Entpr Mergers & Acquisitions A | |||
KCVIX | 17.41 | -0.24 | -1.36% |
Knights of Columbus Large Cap Value I | |||
USGLX | 65.01 | -1.09 | -1.65% |
JHancock U.S. Global Leaders Growth A |